Cas | 204656-20-2 | Molecular Cov Qauv | C172H26N43O51 |
Molecular hnyav | 3751.20 | Kev tshwm sim | Xim dawb |
Chaw Cia Khoom | Lub teeb tiv taus, 2-8 degree | Lub thawv | Aluminium Ntawv Nyiaj Hnab / Vial |
Kev coj dawb huv | ≥96% | Kev mus | Cov Khaub Ncaws Txias Thiab Txias Khoom Siv |
Nquag xyaw:
Liraglutide (analog ntawm tib neeg generide-li peptide-1 (GLP-1) tsim los ntawm cov poov xab hloov tshuab caj ces).
Tshuaj Npe:
Arg34ly26- (n-ε- (γ-gluents (n-α-hexadecanoyl))) - GLP-1 [7-37]
Lwm yam khoom xyaw:
Disodium hydrogen phosphate diosdrate, propylene glycol, hydrochloric acid thiab / lossis sodium hydroxide (li pH cov neeg kho mob nkaus xwb), Phenol, thiab dej rau kev txhaj tshuaj.
Mob Ntshav Qab Zib Hom 2
Liraglutide txhim kho kev tswj cov ntshav ntshav qab zib. Nws txo cov zaub mov-cuam tshuam txog hyperglycemia (rau 24 teev tom qab kev tso nyiaj tsis muaj txiaj ntsig (tsuas yog)
Nws yog qhov haum rau cov neeg mob uas cov ntshav qab zib tseem tsis tau raug tswj hwm tom qab qhov siab tshaj plaws zam kev tawm ntawm cov metformin ib leeg. Nws yog siv hauv kev sib xyaw ua ke nrog Metformin lossis SulfonyLuras.
Nws ua nyob rau hauv ib tug qab zib qab zib-yam ntxwv, txhais tau tias nws yuav txhawb cov kab xev insulin nkaus xwb thaum muaj ntshav qab zib ntshav ntau dua li ib txwm muaj, tiv thaiv "overshoot". Yog li ntawd, nws qhia tau tias tsis tshua muaj pheej hmoo ntawm hypoglycemia.
Nws muaj peev xwm ua rau muaj kev cuam tshuam tsis tau zoo thiab txhawb kev tsim dua tshiab ntawm beta hlwb (pom hauv cov tsiaj kev tshawb fawb).
Nws tsawg zuj zus thiab ua rau lub cev hnyav dua, raws li muaj nyob hauv ib lub taub hau-rau-taub hau kev kawm glimpiride.
Pharmacological txiav txim siab
Liraglutide yog GLP-1 analog nrog 97% ntu homology rau tib neeg GLP-1, uas tuaj yeem khi rau thiab ua kom zoo dua cov GLP-1 tus neeg tau txais. Lub GLP-1 lub hom phiaj yog lub hom phiaj ntawm haiv neeg cov glp-1, ib tug endogenous inconus uas txhawb nqa cov hmoov av tsw qab los ntawm pancreatic β cell. Tsis zoo li ib txwm glp-1, cov tshuaj npauj cev thiab pharmacodynamic profiles hauv tib neeg yog qhov tsim nyog rau ib zaug kev noj tshuaj ib zaug txhua hnub. Tom qab kev txhaj tshuaj, nws cov tshuab ntawm lub caij nyoog ntev suav nrog: Koom haum tus kheej uas ua rau kev nqus dej; khi rau albumin; Siab dua enzyme ruaj khov thiab li no lub plab muaj ib nrab-lub neej.
Cov kev ua ntawm Liraglutide yog kho kom haum los ntawm nws cov kev sib cuam tshuam tshwj xeeb nrog GLP-1 tus neeg tau txais, ua rau muaj kev nce hauv cyclic adenosine monophosphate (chaw pw). Liraglutide stabulates Insulin zais rau hauv cov piam thaj kom zoo-uas muaj yam ntxwv txo qis dua glucib kev zais cia zoo nyob rau hauv cov piam thaj kom zoo.
Yog li ntawd, thaum ntshav qab glucose, insulin zais cia yog txhawb, thaum gluuc magnition yog inhibited. Hauv kev sib piv, Liraglutide txo cov insulin zais rau thaum hypoglycemia tsis cuam tshuam rau cov kev tso tawm glucagon. Lub hypoglycemic mecharic me ntsis ntawm lilaglutide kuj suav nrog lub sijhawm me ntsis ntawm lub sijhawm ua kua roj plab. Liraglutide txo lub cev hnyav thiab lub cev rog los ntawm kev txo kev tshaib plab thiab lub zog.